Among the myriad tumor-associated Ags being investigated as potential CAR T cell targets, human epidermal growth factor receptor 2 (HER2) stands out as a versatile candidate due to its expression in many solid tumors, including breast, colon, and head and neck squamous cell carcinoma (13–15). Here, ERBB2 is linked to head and neck squamous cell carcinoma.